LBP AM’s West Pharmaceutical WST Stock Holding History

LBP AM’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.46M	Buy	4,063 +1,932	+91%	+$591K	0.01%	343
2026 Q1	$534K	Sell	2,131 -19,878	-90%	-$4.95M	0.01%	368
2025 Q4	$6.06M	Buy	22,009 +19,819	+905%	+$5.42M	0.07%	213
2025 Q3	$575K	Buy	+2,190	New	+$532K	0.01%	360
2024 Q2	–	Sell	-3,662	Closed	-$1.45M	–	358
2024 Q1	$1.45M	Sell	3,662 -372	-9%	-$138K	0.06%	195
2023 Q4	$1.42M	Sell	4,034 -1,038	-20%	-$367K	0.03%	294
2023 Q3	$1.9M	Buy	5,072 +11	+0.2%	+$4.25K	0.04%	295
2023 Q2	$1.94M	Sell	5,061 -12,650	-71%	-$4.52M	0.05%	261
2023 Q1	$6.14M	Buy	17,711 +3,535	+25%	+$1.03M	0.16%	136
2022 Q4	$3.34M	Buy	+14,176	New	+$3.36M	0.1%	215

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

LBP AM's WST Position: Q2 2026 in Review

LBP AM increased its West Pharmaceutical (WST) stake by 91% in Q2 2026, buying an estimated $591K and bringing the position to 4,063 shares worth $1.46M. The position accounts for 0.01% of the portfolio, ranked #343.

LBP AM first reported a position in WST in Q4 2022 and has held it in 10 quarters since. The position peaked at $6.14M in Q1 2023. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

LBP AM held 4,063 shares of West Pharmaceutical worth $1.46M as of Q2 2026.
LBP AM bought 1,932 West Pharmaceutical shares in Q2 2026, an estimated $591K.
West Pharmaceutical made up 0.01% of LBP AM's portfolio in Q2 2026, its #343 holding.
LBP AM first reported a position in West Pharmaceutical in Q4 2022 and has held it in 10 quarters since.
LBP AM's West Pharmaceutical position peaked at $6.14M in Q1 2023.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on LBP AM's 13F filing for Q2 2026, filed 24 Jul 2026.